1. Home
  2. OLMA vs SNEX Comparison

OLMA vs SNEX Comparison

Compare OLMA & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • SNEX
  • Stock Information
  • Founded
  • OLMA 2006
  • SNEX 1924
  • Country
  • OLMA United States
  • SNEX United States
  • Employees
  • OLMA N/A
  • SNEX N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • SNEX Investment Bankers/Brokers/Service
  • Sector
  • OLMA Health Care
  • SNEX Finance
  • Exchange
  • OLMA Nasdaq
  • SNEX Nasdaq
  • Market Cap
  • OLMA 465.4M
  • SNEX 3.3B
  • IPO Year
  • OLMA 2020
  • SNEX 1994
  • Fundamental
  • Price
  • OLMA $6.10
  • SNEX $94.66
  • Analyst Decision
  • OLMA Strong Buy
  • SNEX
  • Analyst Count
  • OLMA 5
  • SNEX 0
  • Target Price
  • OLMA $26.25
  • SNEX N/A
  • AVG Volume (30 Days)
  • OLMA 1.1M
  • SNEX 173.7K
  • Earning Date
  • OLMA 11-12-2024
  • SNEX 02-04-2025
  • Dividend Yield
  • OLMA N/A
  • SNEX N/A
  • EPS Growth
  • OLMA N/A
  • SNEX 6.85
  • EPS
  • OLMA N/A
  • SNEX 7.96
  • Revenue
  • OLMA N/A
  • SNEX $98,704,300,000.00
  • Revenue This Year
  • OLMA N/A
  • SNEX N/A
  • Revenue Next Year
  • OLMA N/A
  • SNEX N/A
  • P/E Ratio
  • OLMA N/A
  • SNEX $11.94
  • Revenue Growth
  • OLMA N/A
  • SNEX 64.52
  • 52 Week Low
  • OLMA $5.56
  • SNEX $61.68
  • 52 Week High
  • OLMA $16.78
  • SNEX $106.77
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 27.05
  • SNEX 37.96
  • Support Level
  • OLMA $5.56
  • SNEX $90.87
  • Resistance Level
  • OLMA $6.87
  • SNEX $103.92
  • Average True Range (ATR)
  • OLMA 0.81
  • SNEX 2.49
  • MACD
  • OLMA -0.28
  • SNEX -1.61
  • Stochastic Oscillator
  • OLMA 10.12
  • SNEX 21.42

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About SNEX StoneX Group Inc.

StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: commercial, Institutional, Retail, and Global Payments. Its customers include governmental and nongovernmental organizations, and commercial banks, brokers, institutional investors, and investment banks. The company operates in United States, South America, Europe, Middle East and Asia and other countries, out of which majority revenue is generates from Middle East and Asia Region.

Share on Social Networks: